Effects of the Magenstrasse and Mill Operation for Obesity on Plasma Plasminogen Activator Inhibitor Type 1, Tissue Plasminogen Activator, Fibrinogen and Insulin

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 40-43

Karger

Access to resources Recommend Favorite

A synthetic peptide derived from staphylokinase enhances plasminogen activation by tissue‐type plasminogen activator

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 9, Iss. 5, 2011-05 ,pp. : 997-1006

John Wiley & Sons Inc

Access to resources Recommend Favorite

Regulation of fibrinolysis by C‐terminal lysines operates through plasminogen and plasmin but not tissue‐type plasminogen activator

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 10, Iss. 11, 2012-11 ,pp. : 2354-2360

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Intracoronary Tissue-Type Plasminogen Activator Treatment in Kawasaki Disease and Acute Myocardial Infarction

By  

Cardiology, Vol. 94, Iss. 1, 2000-11 ,pp. : 52-57

Karger

Access to resources Recommend Favorite

Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: Comparison of fibrinogen concentrate with allogeneic blood products

By Solomon Cristina   Schöchl Herbert   Hanke Alexander   Calatzis Andreas   Hagl Christian   Tanaka Kenichi   Rahe-Meyer Niels  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 72, Iss. 2, 2012-04 ,pp. : 121-128

Informa Healthcare

Access to resources Recommend Favorite